RecruitingNCT01656447
Scleroderma Registry & Repository at the Hospital for Special Surgery
The Scleroderma Registry & Repository
Sponsor
Hospital for Special Surgery, New York
Enrollment
300 participants
Start Date
Aug 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Individuals older than 18 years of age with Scleroderma
Exclusion Criteria2
- Individuals younger than 18 years of age
- Individuals older than 18 years of age without Scleroderma
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01656447
Related Trials
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
NCT068011191 location
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
NCT0632877710 locations
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT052514151 location
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
NCT074701511 location
Rheumatology Patient Registry and Biorepository
NCT044020861 location